Atherosclerosis and uremic retention solutes.
Hörl
Walter H
WH
Division of Nephrology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. walter.hoerl@nephro.imed3.akh-wien.ac.at
Cohen
Jordan J
JJ
Harrington
John T
JT
Madias
Nicolas E
NE
Zusman
Cheryl J
CJ
D001120:Arginine / Q000031:analogs & derivatives* / Q000378:metabolism; D001161:Arteriosclerosis / Q000150:complications* / Q000378:metabolism* / Q000401:mortality; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000378:metabolism / Q000401:mortality; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications / Q000378:metabolism / Q000401:mortality; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000401:mortality; D008875:Middle Aged; D009569:Nitric Oxide / Q000378:metabolism; D018384:Oxidative Stress; D010710:Phosphates / Q000378:metabolism; D014511:Uremia / Q000150:complications* / Q000378:metabolism* / Q000401:mortality
D010710:Phosphates; D009569:Nitric Oxide; C018524:N,N-dimethylarginine; D001120:Arginine